Global Medical REIT Inc.
GMRE
$8.02
-$0.57-6.64%
| Weiss Ratings | GMRE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | C+ | |||
| Rating Factors | GMRE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Excellent | |||
| Growth Index | Weak | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | GMRE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.93 | |||
| Price History | GMRE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -4.30% | |||
| 30-Day Total Return | -2.16% | |||
| 60-Day Total Return | 8.14% | |||
| 90-Day Total Return | -2.30% | |||
| Year to Date Total Return | 8.29% | |||
| 1-Year Total Return | 3.40% | |||
| 2-Year Total Return | 5.97% | |||
| 3-Year Total Return | -34.63% | |||
| 5-Year Total Return | 39.37% | |||
| 52-Week High % Change | -17.88% | |||
| 52-Week Low % Change | 17.19% | |||
| Price | GMRE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $10.46 | |||
| 52-Week Low Price | $7.33 | |||
| 52-Week Low Price (Date) | Jan 10, 2025 | |||
| 52-Week High Price (Date) | Sep 19, 2024 | |||
| Valuation | GMRE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 574.42M | |||
| Enterprise Value | 1.30B | |||
| Price/Earnings (TTM) | 721.85 | |||
| Earnings Per Share (TTM) | 0.01 | |||
| Earnings Per Share Growth | -94.73% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 4.14 | |||
| Price/Book (Q) | 1.25 | |||
| Enterprise Value/Revenue (TTM) | 9.36 | |||
| Price | $8.02 | |||
| Enterprise Value/EBITDA (TTM) | 15.39 | |||
| Enterprise Value/EBIT | 39.53 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | GMRE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 66.84M | |||
| Dividend Yield | 9.78% | |||
| Div. Per Share (Most Recent) | $0.21 | |||
| Dividend Per Share (TTM) | $0.84 | |||
| Payout Ratio (TTM) | 990.35% | |||
| Dividend Per Share (Most Recent) | $0.21 | |||
| Company Info | GMRE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 202 524 6851 | |||
| Address | 7373 Wisconsin Avenue Bethesda, MD 20814 | |||
| Website | www.globalmedicalreit.com | |||
| Country | United States | |||
| Year Founded | 2011 | |||
| Profitability | GMRE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 23.68% | |||
| Profit Margin | 4.78% | |||
| Management Effectiveness | GMRE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 1.63% | |||
| Return on Equity | 1.15% | |||
| Income Statement | GMRE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 138.41M | |||
| Total Revenue (TTM) | 138.76M | |||
| Revenue Per Share | $2.08 | |||
| Gross Profit (TTM) | 138.60M | |||
| EBITDA (TTM) | 84.41M | |||
| EBIT (TTM) | 32.87M | |||
| Net Income (TTM) | 6.63M | |||
| Net Income Avl. to Common (TTM) | 811.00K | |||
| Total Revenue Growth (Q YOY) | 6.60% | |||
| Earnings Growth (Q YOY) | 433.39% | |||
| EPS Diluted (TTM) | 0.01 | |||
| EPS Diluted Growth (Q YOY) | 260.94% | |||
| Balance Sheet | GMRE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 25.43M | |||
| Cash Per Share (Q) | $0.38 | |||
| Total Current Assets (Q) | 67.49M | |||
| Total Preferred Equity (Q) | 74.96 | |||
| Total Equity (Q) | 555.92M | |||
| Current Ratio (Q) | 1.436 | |||
| Book Value Per Share (Q) | $6.87 | |||
| Total Assets (Q) | 1.26B | |||
| Total Current Liabilities (Q) | 47.00M | |||
| Total Debt (Q) | 653.59M | |||
| Total Liabilities (Q) | 700.57M | |||
| Total Common Equity (Q) | 459.17M | |||
| Cash Flow | GMRE - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -45.94M | |||
| Cash from Financing (TTM) | -21.89M | |||
| Net Change in Cash (TTM) | 2.22M | |||
| Levered Free Cash Flow (TTM) | 69.51M | |||
| Cash from Operations (TTM) | 70.05M | |||
